[앵커]
As the Corona 19 winter resurgence continued, the most patients occurred in 10 weeks as of Thursday.
From today, the improved vaccine can be given three months after the last vaccination or confirmation.
Reporter Shin Yoon-jung reports.
[기자]
Corona 19 new confirmed cases were 59,089, the most in 10 weeks as of Thursday.
Compared to a week ago or two weeks ago, there were more than 3,000 people, so a moderate increase continued.
The number of severely ill patients continued to exceed 400 for the sixth day, and the number of deaths was 59, 6 more than the previous day.
In preparation for the possibility that the peak time of the recurrent winter season may be earlier than the previous forecast between the end of December and January, the interval between vaccinations with improved vaccines has been shortened to three months.
People who were confirmed or vaccinated before August 26 may receive an additional dose of the bivalent vaccine.
[백경란 / 질병관리청장 : 두 번 이상 접종을 완료하신 분을 대상으로 하기 때문에 기존의 접종 횟수와 무관하게 최종 접종 후 3개월 이상의 시간이 경과했다면….]
The improved vaccine vaccination rate compared to those subject to vaccination is 6.1%, 17% for those over 60 years old, and 18% for nursing hospitals.
The quarantine authorities are working hard to publicize the effectiveness of the improved vaccine, believing that understanding and acknowledgment of the effectiveness is the first step to attract voluntary participation in vaccination.
[이재갑 / 한림대 감염내과 교수 : 지금 유행하고 있는 BA.4·5에 대해서도 효과가 충분하고 지금 유럽이나 미국에서 유행하고 있는 BQ.1이라든지 XBB 타입에 대해서도 충분한 면역을 갖게 될 것으로 예상하고 있습니다.]
In the midst of this, it has been found that the report rate of adverse reactions to improved vaccines so far is about 1/10 of that of existing unit-price vaccines.
It is important to consider that improved vaccination has just begun and there are not many inoculators, but it is noteworthy whether concerns about safety can be reduced.
This is YTN Shin Yoon-jung.
YTN Shin Yun-jeong ([email protected])
※ ‘Your report becomes news’
[카카오톡] Search YTN and add a channel
[전화] 02-398-8585
[메일] [email protected]
[저작권자(c) YTN 무단전재 및 재배포 금지]